Skip to content
PubMed This is a summary of 21 peer-reviewed journal articles Updated
Cardiology · Ankyrin-B Syndrome

Understanding Ankyrin-B Syndrome (LQT4)

At a Glance

Ankyrin-B syndrome is an ANK2-related heart-rhythm condition that may cause slow heart rate, atrial fibrillation, conduction problems, or ventricular arrhythmias, even when the QT interval is normal. A genetic result must be interpreted with ECGs, symptoms, and family history.

Receiving a diagnosis or a genetic report mentioning Ankyrin-B syndrome can be overwhelming, especially when you find it linked to labels like Long QT Syndrome Type 4 (LQT4). While the name sounds intimidating, understanding what this condition actually is—and what it isn’t—is the first step toward managing your health with your medical team.

Ankyrin-B syndrome is a rare genetic condition caused by changes in the ANK2 gene [1]. For many years, it was classified simply as a form of Long QT Syndrome, but researchers now know it is much more complex. Unlike other forms of Long QT that only affect how the heart “recharges” after a beat, Ankyrin-B syndrome can affect the heart’s electrical system in several different ways [2][3].

Beyond the “Long QT” Label

Historically, this condition was called LQT4, but that name is now considered incomplete. Many people with this genetic variant do not actually have a long QT interval on their electrocardiogram (ECG)—the standard test that measures the heart’s electrical activity [2].

Instead of just one electrical issue, Ankyrin-B syndrome is a “broader” syndrome. It can manifest as:

  • Sinus bradycardia or Node Dysfunction: A resting heart rate that is slower than normal, though a slow rate isn’t automatically abnormal depending on age or fitness [4].
  • Atrial fibrillation: An irregular, often rapid heart rhythm originating in the upper chambers of the heart [1].
  • Conduction block: A delay or blockage in the electrical signals as they move through the heart [5].
  • Ventricular arrhythmias: Irregular rhythms in the lower chambers of the heart [6].

Because the condition is so varied, your doctor will likely look at your overall heart rhythm rather than just focusing on the QT interval [7].

Understanding Your Genetic Results

The ANK2 gene provides instructions for a protein that acts like an “anchor,” holding various electrical channels in the right place within heart cells [8]. When this protein doesn’t work correctly, the electrical balance of the heart can be disrupted [9].

If you have been told you have a “variant” in this gene, it is important to know that not all variants cause disease:

  • Autosomal Dominant Inheritance: This means you only need one copy of the changed gene to potentially have the syndrome [1]. However, having the gene does not mean you will definitely get sick.
  • Incomplete Penetrance: This is a medical term meaning that some people carry the genetic change but never develop any symptoms or heart rhythm problems in their lifetime [1][5].
  • Variable Expressivity: Even within the same family, one person might have a slow heart rate while another might have a different rhythm issue, and a third might have no symptoms at all [1][8].

A note on VUS: You may see “Variant of Uncertain Significance” on your report. A VUS means the lab found a change in your DNA, but there isn’t enough scientific evidence yet to know if it actually causes heart problems [10][11]. A VUS should not be used to make major medical decisions or to diagnose the syndrome on its own [12][13].

Why Context Matters

Ankyrin-B syndrome is considered very rare, although the exact number of people affected is unknown [2]. Because the condition is so variable, your clinical “phenotype”—the actual symptoms and test results your doctor sees—is more important than the genetic finding alone [10].

Current guidelines suggest that if a variant is found, it should be evaluated by experts in cardiovascular genetics who can compare your genetic report with your family history and heart tests [14][15]. If you have a VUS, it is often recommended to periodically review the variant classification with your genetic counselor or clinician, as new research may eventually clarify whether that specific change is harmful or benign [16][15].

Living with the Finding

For those who do have confirmed heart rhythm changes associated with ANK2, management is highly personalized. This may involve:

  1. Specialist Monitoring: Regular follow-ups with an electrophysiologist (a heart rhythm specialist) [17].
  2. Medication Review: Avoiding certain drugs that can further disrupt the heart’s electrical rhythm [18][19].
  3. Family Screening: Evaluating close relatives (parents, siblings, and children) with targeted genetic testing or clinical ECGs to see if they share any heart rhythm patterns [7][20].

A genetic finding is a tool for your doctors to better understand your heart, but it is just one piece of the puzzle. Having the variant is not a guarantee of a severe outcome, and many people with ANK2 variants lead full, active lives with appropriate monitoring [21][18].

Common questions in this guide

Is Ankyrin-B syndrome the same as Long QT syndrome type 4?
LQT4 was the historical name for Ankyrin-B syndrome, but it is now considered an incomplete label. ANK2-related disease can involve a slow heart rate, atrial fibrillation, conduction problems, or ventricular arrhythmias even when the QT interval is not prolonged.
Can an ANK2 variant cause heart problems if my QT interval is normal?
A normal QT interval does not rule out an ANK2-related heart-rhythm condition. Clinicians also assess heart rate, rhythm, electrical conduction, symptoms, and results from rhythm monitoring.
Does every ANK2 variant mean I have Ankyrin-B syndrome?
No. Some ANK2 variants do not cause disease, and even a disease-causing variant may never lead to symptoms in a particular person. Doctors interpret the genetic result alongside ECGs, symptoms, family history, and other clinical findings.
What does a VUS in ANK2 mean for my care?
A variant of uncertain significance means there is not enough evidence to tell whether the DNA change affects heart health. It should not be used by itself to diagnose Ankyrin-B syndrome or make major medical decisions, and your clinician or genetic counselor may review it again as evidence changes.
What symptoms can Ankyrin-B syndrome cause?
Possible findings include a slow resting heart rate or sinus-node dysfunction, atrial fibrillation, blocked or delayed electrical conduction, and ventricular arrhythmias. Some people have palpitations or fainting, while others have no symptoms.
How should my family members be evaluated after an ANK2 finding?
Parents, siblings, and children may be considered for a clinical ECG, targeted genetic testing, or both, depending on the variant and family history. A cardiovascular genetics team or heart-rhythm specialist can recommend the appropriate approach.
What specialists and monitoring are usually involved?
People with confirmed heart-rhythm changes may need follow-up with a heart-rhythm specialist, along with ECGs or other rhythm monitoring and a review of medications that can affect the heart’s electrical activity. The plan is individualized because ANK2 findings and symptoms vary widely.

Get notified when new evidence is published on Cardiac arrhythmia, ankyrin-b-related.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (21)
  1. 1

    Mechanisms underlying the role of ankyrin-B in cardiac and neurological health and disease.

    York NS, Sanchez-Arias JC, McAdam ACH, et al.

    Frontiers in cardiovascular medicine 2022; (9()):964675 doi:10.3389/fcvm.2022.964675.

    PMID: 35990955
  2. 2

    Phenotypic Variability of ANK2 Mutations in Patients With Inherited Primary Arrhythmia Syndromes.

    Ichikawa M, Aiba T, Ohno S, et al.

    Circulation journal : official journal of the Japanese Circulation Society 2016; (80(12)):2435-2442 doi:10.1253/circj.CJ-16-0486.

    PMID: 27784853
  3. 3

    The evolving role of ankyrin-B in cardiovascular disease.

    Koenig SN, Mohler PJ

    Heart rhythm 2017; (14(12)):1884-1889 doi:10.1016/j.hrthm.2017.07.032.

    PMID: 28765088
  4. 4

    Long QT Syndrome and Sinus Bradycardia-A Mini Review.

    Wilders R, Verkerk AO

    Frontiers in cardiovascular medicine 2018; (5()):106 doi:10.3389/fcvm.2018.00106.

    PMID: 30123799
  5. 5

    Mechanisms and Alterations of Cardiac Ion Channels Leading to Disease: Role of Ankyrin-B in Cardiac Function.

    Sucharski HC, Dudley EK, Keith CBR, et al.

    Biomolecules 2020; (10(2)) doi:10.3390/biom10020211.

    PMID: 32023981
  6. 6

    Ankyrin-B dysfunction predisposes to arrhythmogenic cardiomyopathy and is amenable to therapy.

    Roberts JD, Murphy NP, Hamilton RM, et al.

    The Journal of clinical investigation 2019; (129(8)):3171-3184.

    PMID: 31264976
  7. 7

    High-degree atrioventricular block in a child with an ANK2 variant and long QT phenotype requiring leadless pacemaker implantation.

    You J

    Cardiology in the young 2026; (36(7)):1532-1535 doi:10.1017/S1047951126123464.

    PMID: 42493853
  8. 8

    Novel Variant in the ANK2 Membrane-Binding Domain Is Associated With Ankyrin-B Syndrome and Structural Heart Disease in a First Nations Population With a High Rate of Long QT Syndrome.

    Swayne LA, Murphy NP, Asuri S, et al.

    Circulation. Cardiovascular genetics 2017; (10(1)) doi:10.1161/CIRCGENETICS.116.001537.

    PMID: 28196901
  9. 9

    A Novel Mechanism for Human Cardiac Ankyrin-B Syndrome due to Reciprocal Chromosomal Translocation.

    Huq AJ, Pertile MD, Davis AM, et al.

    Heart, lung & circulation 2017; (26(6)):612-618 doi:10.1016/j.hlc.2016.09.013.

    PMID: 27916589
  10. 10

    Approaches to Genetic Screening in Cardiomyopathies: Practical Guidance for Clinicians.

    Kontorovich AR

    JACC. Heart failure 2023; (11(2)):133-142 doi:10.1016/j.jchf.2022.11.025.

    PMID: 36754525
  11. 11

    Approach to the patient with a variant of uncertain significance on genetic testing.

    Newey PJ

    Clinical endocrinology 2022; (97(4)):400-408 doi:10.1111/cen.14818.

    PMID: 35996232
  12. 12

    What Is a Variant of Uncertain Significance in Genetic Testing?

    Nicolosi P, Heald B, Esplin ED

    European urology focus 2022; (8(3)):654-656 doi:10.1016/j.euf.2022.03.018.

    PMID: 35422376
  13. 13

    Tips for Testing Adults With Suspected Genetic Kidney Disease.

    Savige J

    American journal of kidney diseases : the official journal of the National Kidney Foundation 2024; (83(6)):816-824 doi:10.1053/j.ajkd.2023.10.011.

    PMID: 38147894
  14. 14

    Interpretation and actionability of genetic variants in cardiomyopathies: a position statement from the European Society of Cardiology Council on cardiovascular genomics.

    Arbustini E, Behr ER, Carrier L, et al.

    European heart journal 2022; (43(20)):1901-1916 doi:10.1093/eurheartj/ehab895.

    PMID: 35089333
  15. 15

    The frequency of gene variant reclassification and its impact on clinical management in the inherited arrhythmia clinic.

    Young WJ, Maung S, Ahmet S, et al.

    Heart rhythm 2024; (21(6)):903-910 doi:10.1016/j.hrthm.2024.01.008.

    PMID: 38218330
  16. 16

    Reassessment and reclassification of variants of unknown significance in patients with cardiomyopathy in a specialist department.

    Horgan S, Kotwal H, Malan A, et al.

    Journal of medical genetics 2025; (62(3)):185-190 doi:10.1136/jmg-2024-110208.

    PMID: 39694818
  17. 17

    Genetic analysis of Iranian family with hereditary cardiac arrhythmias by next generation sequencing.

    Asadi M, Foo R, Samienasab MR, et al.

    Advanced biomedical research 2016; (5()):55 doi:10.4103/2277-9175.178801.

    PMID: 27110552
  18. 18

    Congenital Long QT Syndrome.

    Krahn AD, Laksman Z, Sy RW, et al.

    JACC. Clinical electrophysiology 2022; (8(5)):687-706 doi:10.1016/j.jacep.2022.02.017.

    PMID: 35589186
  19. 19

    Vigorous Exercise in Patients With Congenital Long QT Syndrome: Results of the Prospective, Observational, Multinational LIVE-LQTS Study.

    Lampert R, Day S, Ainsworth B, et al.

    Circulation 2024; (150(7)):516-530 doi:10.1161/CIRCULATIONAHA.123.067590.

    PMID: 39051104
  20. 20

    CONGENITAL LONG QT SYNDROME: A SYSTEMATIC REVIEW.

    Galić E, Bešlić P, Kilić P, et al.

    Acta clinica Croatica 2021; (60(4)):739-748 doi:10.20471/acc.2021.60.04.22.

    PMID: 35734489
  21. 21

    Avoiding sports-related sudden cardiac death in children with congenital channelopathy : Recommendations for sports activities.

    Lang CN, Steinfurt J, Odening KE

    Herz 2017; (42(2)):162-170 doi:10.1007/s00059-017-4549-2.

    PMID: 28233036

This page is for informational purposes only and does not constitute medical advice. A cardiologist, electrophysiologist, or genetics professional should interpret your ANK2 results and guide your care.